Cargando…
Earth-friendly-assessed silver-nanoparticles spectrophotometric method for rapid and sensitive analysis of Molnupiravir, an FDA-approved candidate for COVID-19: application on pharmaceutical formulation and dissolution test
Molnupiravir is the first oral direct-acting antiviral prodrug recently approved for the COVID-19 pandemic. Here and for the first time, we present a novel, sensitive, robust, and simple silver-nanoparticles spectrophotometric technique for molnupiravir analysis in its capsules and dissolution media...
Autores principales: | Mohamed, Ahmed R., Abolmagd, Ebrahim, Nour, Israa M., Badrawy, Mohamed, Hasan, Mohamed A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9999326/ https://www.ncbi.nlm.nih.gov/pubmed/36899439 http://dx.doi.org/10.1186/s13065-023-00933-2 |
Ejemplares similares
-
Green adherent spectrophotometric determination of molnupiravir based on computational calculations; application to a recently FDA-approved pharmaceutical dosage form
por: Abdelazim, Ahmed H., et al.
Publicado: (2023) -
Development and validation of molnupiravir assessment in bulk powder and pharmaceutical formulation by the RP-HPLC-UV method
por: Annadi, Abdelaziz M., et al.
Publicado: (2022) -
Molnupiravir: First Approval
por: Syed, Yahiya Y.
Publicado: (2022) -
Simultaneous spectrophotometric determination of finasteride and tadalafil in recently FDA approved Entadfi™ capsules
por: Abdelazim, Ahmed H., et al.
Publicado: (2022) -
A Comprehensive Map of FDA-Approved Pharmaceutical Products
por: Zhong, Hao, et al.
Publicado: (2018)